EXPEDIA GROUP INC (EXPE)

US30212P3038 - Common Stock

184.75  +5.34 (+2.98%)

After market: 184.75 0 (0%)

Fundamental Rating

5

Taking everything into account, EXPE scores 5 out of 10 in our fundamental rating. EXPE was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. EXPE scores excellent on profitability, but there are concerns on its financial health. EXPE scores decently on growth, while it is valued quite cheap. This could make an interesting combination.



7

1. Profitability

1.1 Basic Checks

In the past year EXPE was profitable.
EXPE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXPE reported negative net income in multiple years.
Of the past 5 years EXPE 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of EXPE (4.53%) is better than 67.16% of its industry peers.
With an excellent Return On Equity value of 80.26%, EXPE belongs to the best of the industry, outperforming 98.51% of the companies in the same industry.
EXPE has a better Return On Invested Capital (11.64%) than 76.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPE is below the industry average of 10.55%.
The last Return On Invested Capital (11.64%) for EXPE is above the 3 year average (6.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROIC 11.64%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 7.92%, EXPE is in the better half of the industry, outperforming 67.91% of the companies in the same industry.
EXPE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 11.41%, EXPE is in line with its industry, outperforming 57.46% of the companies in the same industry.
In the last couple of years the Operating Margin of EXPE has grown nicely.
EXPE has a better Gross Margin (89.17%) than 99.25% of its industry peers.
EXPE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%

3

2. Health

2.1 Basic Checks

EXPE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, EXPE has less shares outstanding
The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
The debt/assets ratio for EXPE has remained at the same level compared to a year ago.

2.2 Solvency

EXPE has an Altman-Z score of 1.25. This is a bad value and indicates that EXPE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.25, EXPE is in line with its industry, outperforming 42.54% of the companies in the same industry.
EXPE has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as EXPE would need 3.28 years to pay back of all of its debts.
The Debt to FCF ratio of EXPE (3.28) is better than 78.36% of its industry peers.
EXPE has a Debt/Equity ratio of 3.95. This is a high value indicating a heavy dependency on external financing.
EXPE has a Debt to Equity ratio (3.95) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Altman-Z 1.25
ROIC/WACC1.5
WACC7.76%

2.3 Liquidity

A Current Ratio of 0.73 indicates that EXPE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.73, EXPE is doing worse than 62.69% of the companies in the same industry.
EXPE has a Quick Ratio of 0.73. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EXPE (0.73) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73

6

3. Growth

3.1 Past

EXPE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.61%, which is quite impressive.
Measured over the past years, EXPE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.07% on average per year.
EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.56%.
The Revenue has been growing slightly by 2.73% on average over the past years.
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%

3.2 Future

Based on estimates for the next years, EXPE will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.25% on average per year.
EXPE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y16.25%
Revenue Next Year5.81%
Revenue Next 2Y6.82%
Revenue Next 3Y6.88%
Revenue Next 5Y6.43%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.97, EXPE is valued correctly.
80.60% of the companies in the same industry are more expensive than EXPE, based on the Price/Earnings ratio.
EXPE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
EXPE is valuated correctly with a Price/Forward Earnings ratio of 12.86.
86.57% of the companies in the same industry are more expensive than EXPE, based on the Price/Forward Earnings ratio.
EXPE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 15.97
Fwd PE 12.86

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPE is valued a bit cheaper than the industry average as 64.93% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EXPE is valued cheaply inside the industry as 88.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.43
EV/EBITDA 10.53

4.3 Compensation for Growth

EXPE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EXPE may justify a higher PE ratio.
A more expensive valuation may be justified as EXPE's earnings are expected to grow with 20.88% in the coming years.
PEG (NY)0.71
PEG (5Y)1.44
EPS Next 2Y20.97%
EPS Next 3Y20.88%

0

5. Dividend

5.1 Amount

EXPE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXPEDIA GROUP INC

NASDAQ:EXPE (12/20/2024, 8:07:58 PM)

After market: 184.75 0 (0%)

184.75

+5.34 (+2.98%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners98.77%
Inst Owner Change-1.8%
Ins Owners0.49%
Ins Owner Change-0.11%
Market Cap23.71B
Analysts70.7
Price Target188.23 (1.88%)
Short Float %3.54%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.75%
Min EPS beat(2)-0.95%
Max EPS beat(2)12.45%
EPS beat(4)3
Avg EPS beat(4)49.72%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)5
Avg EPS beat(8)-22.96%
EPS beat(12)8
Avg EPS beat(12)-7.24%
EPS beat(16)10
Avg EPS beat(16)-4.01%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)0.87%
Revenue beat(8)1
Avg Revenue beat(8)-1.79%
Revenue beat(12)2
Avg Revenue beat(12)-1.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.92%
PT rev (1m)20.95%
PT rev (3m)23.93%
EPS NQ rev (1m)0.16%
EPS NQ rev (3m)-12.94%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 15.97
Fwd PE 12.86
P/S 1.77
P/FCF 12.43
P/OCF 8.95
P/B 17.94
P/tB N/A
EV/EBITDA 10.53
EPS(TTM)11.57
EY6.26%
EPS(NY)14.37
Fwd EY7.78%
FCF(TTM)14.86
FCFY8.04%
OCF(TTM)20.64
OCFY11.17%
SpS104.36
BVpS10.3
TBVpS-50.46
PEG (NY)0.71
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 80.26%
ROCE 17.73%
ROIC 11.64%
ROICexc 27.12%
ROICexgc N/A
OM 11.41%
PM (TTM) 7.92%
GM 89.17%
FCFM 14.24%
ROA(3y)1.36%
ROA(5y)-1.53%
ROE(3y)18.1%
ROE(5y)-7.52%
ROIC(3y)6.14%
ROIC(5y)N/A
ROICexc(3y)10.39%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.36%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y20.18%
OM growth 3YN/A
OM growth 5Y10.37%
PM growth 3YN/A
PM growth 5Y11.4%
GM growth 3Y9.04%
GM growth 5Y1.24%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF 3.28
Debt/EBITDA 2.21
Cap/Depr 88.97%
Cap/Sales 5.54%
Interest Coverage 6.61
Cash Conversion 112.15%
Profit Quality 179.74%
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 1.25
F-Score8
WACC7.76%
ROIC/WACC1.5
Cap/Depr(3y)90.37%
Cap/Depr(5y)94.64%
Cap/Sales(3y)6.7%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.61%
EPS 3YN/A
EPS 5Y11.07%
EPS Q2Q%13.31%
EPS Next Y22.39%
EPS Next 2Y20.97%
EPS Next 3Y20.88%
EPS Next 5Y16.25%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y35.17%
Revenue growth 5Y2.73%
Sales Q2Q%3.33%
Revenue Next Year5.81%
Revenue Next 2Y6.82%
Revenue Next 3Y6.88%
Revenue Next 5Y6.43%
EBIT growth 1Y11.13%
EBIT growth 3YN/A
EBIT growth 5Y13.38%
EBIT Next Year129.5%
EBIT Next 3Y40.63%
EBIT Next 5Y26.29%
FCF growth 1Y-41.84%
FCF growth 3YN/A
FCF growth 5Y10.95%
OCF growth 1Y-32.2%
OCF growth 3YN/A
OCF growth 5Y6.37%